Ultrahuman has launched M2 Live, a new wearable glucose monitoring device powered by Abbott's Lingo sensor, marking a significant step forward in making continuous glucose monitoring technology more widely available to people managing diabetes.

The innovation combines real-time glucose tracking with user-friendly technology, helping individuals better understand how their bodies respond to food, exercise, and stress. Continuous glucose monitoring has traditionally been reserved for insulin-dependent diabetics, but this advancement opens the door to broader accessibility for anyone interested in optimizing their metabolic health. Read the full story →

Today's takeaway: Technology that empowers people to take control of their health through better data is a win for preventive wellness.